Venient Fx Prostate Function Basic

Test Description

Venient Cx Prostate Function Basic is a disruptive and non-invasive test that provides primary information about the prostate function of the patient. It is based on a routine blood analysis and powered by both public and proprietary machine learning (ML) algorithms, and it delivers high accurate primary diagnostic information including likelihood of having any type of prostate dysfunctions. As a primary election test, the results of the parameters included on it are helpful in order to orientate through different diagnostic, prognostic and therapeutic options. Although normally the results are preliminary in decision making, in some cases, they can be definitive. 

In case of a positive result, the diagnostic report will suggest performing a certain secondary election test, in order to deepen the diagnostic information, confirm therapies, stablish prognostics or perform the follow-up of the disease.

United States Preventative Services Task Force (USPSTF) screening recommendations

Although the USPSTF (United States Preventative Services Task Force) only recommends prostate screening for prostate cancer, Kience Inc. recommends our laboratory-developed test (LDT) Venient Cx Prostate Function Basic to address all men who present the following symptoms, signs or suspected diseases: need to urinate frequently (frequent urination) or urgently; difficulty starting to urinate; weak urine flow or that stops and starts again; dripping after urination; not being able to completely empty the bladder; benign prostatic hyperplasia (BPH), acute prostatitis (AP) or chronic prostatitis (CP), among others.

Intended Use

The intended population for Venient Cx Prostate Function Basic are all men who present the following symptoms, signs or suspected diseases: need to urinate frequently (frequent urination) or urgently; difficulty starting to urinate; weak urine flow or that stops and starts again; dripping after urination; not being able to completely empty the bladder; benign prostatic hyperplasia (BPH), acute prostatitis (AP) or chronic prostatitis (CP), among others.

Sample Clinical Vignette

A 60-year-old male presented for medical evaluation after a 6-month history of nocturia, difficulty for initiating urination, weak urine flow, sensation of bladder urgency and post-void dribbling. Serum is submitted to detect possible alteration in his prostate (e.g. prostatitis or benign prostate hyperplasia), which could be related with his symptoms.

Required Laboratory Determinations

Serum Tumor Markers —Prostate-Specific Antigen Total (PSA Total), Prostate-Specific Antigen Free (PSA Free)—.